Page last updated: 2024-08-25

chitosan and ondansetron

chitosan has been researched along with ondansetron in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Goel, H; Rana, V; Tiwary, AK; Vora, N2
Arora, A; Goel, H; Rana, V; Tiwary, AK1
Baktir, G; Erturk-Toker, S; Gungor, S; Okyar, A; Ozsoy, Y1
Jee, JP; Kim, CK; Kim, HT; Park, DM; Song, YK1
Can, AS; Erdal, MS; Güngör, S; Özsoy, Y1
Mahajan, HS; Sonje, AG1
Abruzzo, A; Bigucci, F; Cerchiara, T; Dalena, F; Giordani, B; Luppi, B; Nicoletta, FP; Prata, C1

Other Studies

8 other study(ies) available for chitosan and ondansetron

ArticleYear
Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride.
    Pharmaceutical development and technology, 2009, Volume: 14, Issue:5

    Topics: Administration, Oral; Chitosan; Drug Compounding; Glycine; Hardness; Ondansetron; Serotonin Antagonists; Solubility; Tablets

2009
Formulation of orodispersible tablets of ondansetron HCl: investigations using glycine-chitosan mixture as superdisintegrant.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:5

    Topics: Antiemetics; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Glycine; Ondansetron; Serotonin Antagonists; Tablets

2009
Development and evaluation of mathematical model to predict disintegration time of fast disintegrating tablets using powder characteristics.
    Pharmaceutical development and technology, 2011, Volume: 16, Issue:1

    Topics: Adsorption; Chemistry, Pharmaceutical; Chitosan; Compressive Strength; Domperidone; Drug Stability; Excipients; Glycine; Metoclopramide; Models, Chemical; Ondansetron; Powders; Solubility; Tablets; Time Factors; Water

2011
Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
    Drug development and industrial pharmacy, 2010, Volume: 36, Issue:7

    Topics: Administration, Intranasal; Animals; Antiemetics; Biological Availability; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Male; Microspheres; Ondansetron; Particle Size; Rats; Rats, Wistar; Technology, Pharmaceutical

2010
Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis.
    Drug development and industrial pharmacy, 2012, Volume: 38, Issue:9

    Topics: Absorption; Adhesiveness; Administration, Buccal; Animals; Antiemetics; Biological Availability; Chitosan; Cricetinae; Drug Compounding; Excipients; Gels; Half-Life; Male; Mesocricetus; Mouth Mucosa; Ondansetron; Pharmaceutical Vehicles; Serotonin 5-HT3 Receptor Antagonists; Solubility; Vomiting

2012
Optimization and characterization of chitosan films for transdermal delivery of ondansetron.
    Molecules (Basel, Switzerland), 2013, May-10, Volume: 18, Issue:5

    Topics: Administration, Cutaneous; Animals; Anti-Anxiety Agents; Chitosan; Humans; Ondansetron; Swine; Transdermal Patch

2013
Nasal inserts containing ondansetron hydrochloride based on Chitosan-gellan gum polyelectrolyte complex: In vitro-in vivo studies.
    Materials science & engineering. C, Materials for biological applications, 2016, Jul-01, Volume: 64

    Topics: Animals; Chitosan; Drug Delivery Systems; Nasal Mucosa; Ondansetron; Polyelectrolytes; Polysaccharides, Bacterial; Sheep

2016
Ondansetron buccal administration for paediatric use: A comparison between films and wafers.
    International journal of pharmaceutics, 2020, Apr-30, Volume: 580

    Topics: Adhesiveness; Administration, Buccal; Animals; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Chitosan; Dosage Forms; Drug Compounding; Drug Delivery Systems; Freeze Drying; Gelatin; Mouth Mucosa; Ondansetron; Pediatrics; Swine

2020